EUVIMEDEUVIMED entdecken
Übersichtsarbeit

CRISPR/Cas gene editing of haematopoietic stem cells for curing primary immunodeficiency

Rasmus O Bak, Mette Holm, Bjarne Møller, Jacob Giehm Mikkelsen, Trine H Mogensen

Ugeskrift for Læger · 2025

DOI: 10.61409/v02250083 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Ugeskrift for Læger, 2025. Verfasst von Rasmus O Bak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institut for Biomedicin, Aarhus Universitet. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems, Hematopoietic Stem Cells, Primary Immunodeficiency Diseases. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary immunodeficiencies are rare monogenic inborn errors of immunity and can involve any combination of infection, autoimmunity, inflammation, and malignancy. While increased use of whole genome sequencing has vastly improved diagnosis, curative treatment options beyond haematopoietic stem cell transplantation are still lacking behind. In this review, we present and discuss the promising avenues of CRISPR/Cas gene editing of patient stem cells for curing these diseases through homology-directed repair, base- or prime editing and delivery by nanoparticles or viral derivatives. However, technological, regulatory, and economic challenges exist on the road to safe and broad implementation of this technology for personalized medicine in the clinic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene EditingCRISPR-Cas SystemsHematopoietic Stem CellsPrimary Immunodeficiency DiseasesImmunologic Deficiency SyndromesHumansGenetic TherapyHematopoietic Stem Cell Transplantation

Autor:innen und Institutionen

  • Institut for Biomedicin, Aarhus Universitet.
  • PASCAL-MID, Aarhus Universitet og Aarhus Universitetshospital.
  • Børn og Unge, Aarhus Universitetshospital.
  • Blodbank og Immunologi, Aarhus Universitetshospital.
  • Infektionssygdomme, Aarhus Universitetshospital.

Zitieren

APA

Bak, R. O., Holm, M., Møller, B., Mikkelsen, J. G., & Mogensen, T. H. (2025). CRISPR/Cas gene editing of haematopoietic stem cells for curing primary immunodeficiency. Ugeskrift for Læger. https://doi.org/10.61409/v02250083

Vancouver

Bak RO, Holm M, Møller B, Mikkelsen JG, Mogensen TH. CRISPR/Cas gene editing of haematopoietic stem cells for curing primary immunodeficiency. Ugeskrift for Læger. 2025. doi:10.61409/v02250083

BibTeX
@article{Bak2025,
  author = {Bak, Rasmus O and Holm, Mette and Møller, Bjarne and Mikkelsen, Jacob Giehm and Mogensen, Trine H},
  title = {CRISPR/Cas gene editing of haematopoietic stem cells for curing primary immunodeficiency},
  journal = {Ugeskrift for Læger},
  year = {2025},
  doi = {10.61409/v02250083}
}
Kostenlos starten →